Evidence map›Paper›PMID 35817965›Full record

ArticleNature materials2022

Mechanical checkpoint regulates monocyte differentiation in fibrotic niches.

Kyle H Vining, Anna E Marneth, Kwasi Adu-Berchie, Joshua M Grolman, Christina M Tringides, Yutong Liu, Waihay J Wong, Olga Pozdnyakova, Mariano Severgnini, Alexander Stafford and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Kyle H Vining *John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-4009-879X
Anna E Marneth *Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
Kwasi Adu-BerchieJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0002-1959-6794
Joshua M GrolmanJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Christina M TringidesHarvard Program in Biophysics, Harvard University, Cambridge, MA, USA.ORCID 0000-0003-2747-1200
Yutong LiuJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0001-5683-5451
Waihay J WongDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Olga PozdnyakovaDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mariano SevergniniCenter for Immuno-Oncology Immune Assessment Laboratory at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Alexander StaffordWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.
Georg N DudaWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.ORCID 0000-0001-7605-3908
F Stephen HodiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ann MullallyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Kai W WucherpfennigDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. kai_wucherpfennig@dfci.harvard.edu.ORCID 0000-0002-1829-302X
David J MooneyJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA. mooneyd@seas.harvard.edu.ORCID 0000-0001-6299-1194
Harvard University · USBrigham and Women's Hospital · USDana-Farber Cancer Institute · USUniversity of the Sciences · US

Funding

Therapeutic Targeting of Immune Evasion from the MICA - NKG2D PathwayR01CA238039 · NCI · DANA-FARBER CANCER INST · PI Kai W Wucherpfennig · 2019 to 2026
$4.2M
3D Models of ImmunotherapyU01CA214369 · NCI · HARVARD UNIVERSITY · PI HODI, FRANK S, LEWIS, JENNIFER A. · 2017 to 2021
$2.9M
Scaffolds mimicking antigen presenting cellsR01FD006589 · FDA · HARVARD UNIVERSITY · PI MOONEY, DAVID J · 2018 to 2020
$1.8M
Targeting mechanical regulation of monocyte fate in head and neck cancer.R00DE030084 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI VINING, KYLE HOLMBERG · 2022 to 2024
$747k
Anti-Inflammatory Mesenchymal Stem Cell Therapy for Dental ApplicationsK08DE025292 · NIDCR · HARVARD UNIVERSITY · PI VINING, KYLE HOLMBERG · 2016 to 2020
$635k
Targeting mechanical regulation of monocyte fate in head and neck cancer.K99DE030084 · NIDCR · DANA-FARBER CANCER INST · PI VINING, KYLE HOLMBERG · 2021 to 2022
$270k
FDA HHS R01 FD006589NCI NIH HHS R01 CA238039NCI NIH HHS U01 CA214369NIDCR NIH HHS K08 DE025292NIDCR NIH HHS K99 DE030084NIDCR NIH HHS R00 DE030084
6 · The paper itself

Abstract

Myelofibrosis is a progressive bone marrow malignancy associated with monocytosis, and is believed to promote the pathological remodelling of the extracellular matrix. Here we show that the mechanical properties of myelofibrosis, namely the liquid-to-solid properties (viscoelasticity) of the bone marrow, contribute to aberrant differentiation of monocytes. Human monocytes cultured in stiff, elastic hydrogels show proinflammatory polarization and differentiation towards dendritic cells, as opposed to those cultured in a viscoelastic matrix. This mechanically induced cell differentiation is blocked by inhibiting a myeloid-specific isoform of phosphoinositide 3-kinase, PI3K-γ. We further show that murine bone marrow with myelofibrosis has a significantly increased stiffness and unveil a positive correlation between myelofibrosis grading and viscoelasticity. Treatment with a PI3K-γ inhibitor in vivo reduced frequencies of monocyte and dendritic cell populations in murine bone marrow with myelofibrosis. Moreover, transcriptional changes driven by viscoelasticity are consistent with transcriptional profiles of myeloid cells in other human fibrotic diseases. These results demonstrate that a fibrotic bone marrow niche can physically promote a proinflammatory microenvironment.

Indexed as

Primary MyelofibrosisAnimalsBone MarrowCell DifferentiationFibrosisHumansMiceMonocytesPhosphatidylinositol 3-Kinases

Identifiers

PMID35817965
PMCPMC10197159
OpenAlexW4285013325

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.